Thompson Peter A. has filed 55 Form 4s with the SEC that we hold, for Sionna Therapeutics, Inc. (SION) (Director), Corvus Pharmaceuticals, Inc. (CRVS) (Director, 10% owner), ARS Pharmaceuticals, Inc. (SPRY) (Director) and Edgewise Therapeutics, Inc. (EWTX) (Director, 10% owner), among 7 companies in all. Across all of them we count 9 purchases worth $43.5M and 39 sales worth $119.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 20 sales ($55.7M). The largest single trade was a sale of 1,195,683 shares of ALPN worth $21.9M, dated 2023-12-28. The first filing on our record is dated 2021-09-13 and the latest 2026-07-09.
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings
this reporting owner (SEC CIK 1357522) filed on EDGAR. Values are the transaction values
as filed. See every filing on EDGAR,
or browse insider buying and
today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-27 ·
For informational purposes only, not investment advice. Privacy · Terms
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.
